- Trials with a EudraCT protocol (207)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
207 result(s) found for: Statins.
Displaying page 2 of 11.
EudraCT Number: 2007-006035-32 | Sponsor Protocol Number: 2300/2007 | Start Date*: 2007-11-15 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Assessment of endothelial function and vasal response in patients with Systemic Sclerosis and Hypercholesterolemia, before and after simvastatin treatment. | |||||||||||||
Medical condition: Systemic Sclerosis and Hypercholesterolemia. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001711-30 | Sponsor Protocol Number: RIMON_R_00961 | Start Date*: 2006-10-11 | |||||||||||
Sponsor Name:sanofi aventis Groupe | |||||||||||||
Full Title: A Pan-European randomized, parallel group, two-arm placebo-controlled, double-blind multicenter study of Rimonabant 20mg once daily in the treatment of abdominally obese patients with impaired fast... | |||||||||||||
Medical condition: abdominally obese patients with impaired fasting blood glucose with or without other comorbidities | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) BE (Completed) PT (Prematurely Ended) CZ (Completed) SI (Completed) FR (Completed) NL (Prematurely Ended) NO (Completed) FI (Prematurely Ended) SE (Prematurely Ended) DK (Prematurely Ended) LT (Prematurely Ended) HU (Completed) SK (Completed) GR (Completed) AT (Prematurely Ended) IT (Prematurely Ended) BG (Prematurely Ended) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000462-62 | Sponsor Protocol Number: Statex1 | Start Date*: 2015-09-23 |
Sponsor Name:Radboud university medical centre | ||
Full Title: The effects of statins on skeletal muscle mitochondria: is exercise the medicine? | ||
Medical condition: Asymp and symp statin users will undergo baseline measurements of skeletal muscle mitochondrial function and muscle function after which they will be switched to a single-blind placebo intervention... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-003009-31 | Sponsor Protocol Number: HH007 | Start Date*: 2022-12-23 | |||||||||||
Sponsor Name:Zealand University Hospital, dept. of Haematology | |||||||||||||
Full Title: Atorvastatin for patients with Philadelphia-negative chronic myeloproliferative neoplasms - Essential thrombocythemia, polycythemia vera and prefibrotic myelofibrosis | |||||||||||||
Medical condition: Essential thrombocythemia, Polycythemia vera, prefibrotic myelofibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004208-37 | Sponsor Protocol Number: S63190 | Start Date*: 2020-08-03 |
Sponsor Name:UZ Leuven | ||
Full Title: Drug repurposing - Statins as microbiota modulating agents in ulcerative colitis | ||
Medical condition: There are two population groups, 20 healthy volunteers and at least 165 individuals diagnosed with IBD. Either with remission to mild/moderate active ulcerative colitis or remission to mild Crohn's... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001226-10 | Sponsor Protocol Number: B1481015 | Start Date*: 2012-08-10 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017 | |||||||||||||
Full Title: A PHASE 2B DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE-RANGING STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 FOLLOWING MONTHLY AND TWICE MONTHLY SUBC... | |||||||||||||
Medical condition: Hyperlipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003114-13 | Sponsor Protocol Number: 1 | Start Date*: 2012-12-07 |
Sponsor Name:West Hertfordshire Hospitals NHS Trust | ||
Full Title: Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in mechanically ventilated patients at high risk of delirium | ||
Medical condition: Delirium | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-005524-42 | Sponsor Protocol Number: 13-1-501 | Start Date*: 2015-03-10 | |||||||||||
Sponsor Name:Reade | |||||||||||||
Full Title: Prevention of rheumatoid arthritis by atorvastatin in seropositive arthralgia patients: a multi-center doubleblind randomized placebo-controlled trial | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001414-33 | Sponsor Protocol Number: RGHT 000275 | Start Date*: 2006-08-01 |
Sponsor Name:The Royal Group Hospitals Trust | ||
Full Title: The effect of hydroxyl-methyl coenzyme A reductase inhibition (statins) in patients with acute lung injury(ALI) and the acute respiratory distress syndrome(ARDS) | ||
Medical condition: Acute Lung Injury (ALI) and the Acute Respiratory Distress Syndrome (ARDS) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003396-20 | Sponsor Protocol Number: MMUH-Conway01 | Start Date*: 2012-11-26 |
Sponsor Name:Cardiothoracic Surgery, Mater Misericordiae University Hospital | ||
Full Title: Is the optimal dose of preoperative statin associated with decreased end organ injury and better clinical outcome post cardiopulmonary bypass? | ||
Medical condition: Patient listed for open heart surgery involving cardiopulmonary bypass. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-009334-32 | Sponsor Protocol Number: 07012009 | Start Date*: 2009-12-28 |
Sponsor Name:University medical center Utrecht | ||
Full Title: Effect of Statins on Sympathetic Activity in Hypertensive Patients with Chronic Kidney Disease: a Randomized trial in Hypertensive Patients with Chronic Kidney Disease | ||
Medical condition: atients older than 18 years old with stable chronic kidney disease and hypertension are included in this project. Patients with diabetes mellitus, patients on renal replacement therapy, patients on... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001795-19 | Sponsor Protocol Number: Uni-Koeln-1341 | Start Date*: 2012-09-13 |
Sponsor Name:University of Cologne | ||
Full Title: STATIN RECAPTURE THERAPY BEFORE CORONARY ARTERY BYPASS GRAFTING (ACRONYM: START-CABG TRIAL) | ||
Medical condition: Patients on a long term statin therapy with established coronary artery disease (CAD) scheduled for isolated surgical myocardial revascularisation (i.e. CABG) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-014913-28 | Sponsor Protocol Number: 09_056R | Start Date*: 2011-02-03 |
Sponsor Name:London School of Hygiene & Tropical Medicine | ||
Full Title: RETRO-PRO: The effectiveness of simvastatin compared to atorvastatin: an e-clinical randomised trial within a research database in routine clinical practice - a feasibility study | ||
Medical condition: subjects who in the opinion of the GP investigator would require a statin for primary prevention according to the 2008 NICE guideline on lipid modification: adults over 40 who have a 20% or greater... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-008376-14 | Sponsor Protocol Number: COD_REG_46_DGR _13751_07 | Start Date*: 2009-02-24 | |||||||||||
Sponsor Name:AZIENDA ASL BRESCIA | |||||||||||||
Full Title: A PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED TRIAL TO INVESTIGATE EFFICACY AND SAFETY OF COMBINED TREATMENT OF GUGGULU AND TRIPHALA FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA AND OVERWEIGHT IN SUB... | |||||||||||||
Medical condition: high blood cholesterol overweight | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018491-24 | Sponsor Protocol Number: 31295 | Start Date*: 2010-07-15 | |||||||||||
Sponsor Name:Vrije Universiteit Medical Center | |||||||||||||
Full Title: Effect of aminobisphosphonates and statins on circulating Vy9Vd2-T cells | |||||||||||||
Medical condition: patients with malignant bone metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005140-24 | Sponsor Protocol Number: ISIS 301012-CS19 | Start Date*: 2008-06-05 | |||||||||||
Sponsor Name:Isis Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled STudy to Assess Safety and Efficacy of ISIS 301012 Administration in Statin Intolerant Subjects | |||||||||||||
Medical condition: Patients with hypercholesterolemia who are intolerant to statins | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001559-15 | Sponsor Protocol Number: CTO#2095 | Start Date*: 2022-11-11 | |||||||||||
Sponsor Name:Ottawa Hospital Research Institute | |||||||||||||
Full Title: StAtins for Venous Event Reduction in Patients with Venous Thromboembolism | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005985-30 | Sponsor Protocol Number: rosucaf2 | Start Date*: 2009-01-22 | |||||||||||
Sponsor Name:Department of Pharmacology-Toxicology | |||||||||||||
Full Title: Is augmentation of PORH by rosuvastatin adenosine-receptor mediated? | |||||||||||||
Medical condition: mechanism of influence of statins on human adaptive mechanisms in hypoxic circumstances | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004863-32 | Sponsor Protocol Number: BCBE/04/NEB-PAO/087 | Start Date*: 2006-03-08 |
Sponsor Name:Berlin-Chemie Menarini | ||
Full Title: EFFECTS OF NEBIVOLOL ON THE WALKING ABILITY IN PATIENTS WITH ESSENTIAL HYPERTENSION AND PERIPHERAL ARTERIAL DISEASE INTERMITTENT CLAUDICATION | ||
Medical condition: ESSENTIAL HYPERTENSION AND PERIPHERAL ARTERIAL DISEASE INTERMITTENT CLAUDICATION | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001994-24 | Sponsor Protocol Number: atorvastatin | Start Date*: 2004-11-09 |
Sponsor Name:Karolinska Institute Danderyd Hospital | ||
Full Title: Effects of atorvastatin on plasma fibrin gel structure and skin microvascular reactivity in patients with type 1 diabetes and dyslipidemia | ||
Medical condition: Hyperlipidemia in patients with diabetes seems associated with a thrombogenic plasma fibrin gel structure and impaired microvascular function. We hypothesize that lipid lowering with a statin leads... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
